Table 2.
Variable | Statistics |
---|---|
Subjects analyzed (N) | 99 |
Mean age (years) ± SD | 66.4 ± 10.9 |
Range | 34–94 |
Gender | |
Male | 43 (43%) |
Female | 56 (57%) |
Race/ethnicity | |
White | 95 (96%) |
Eye | |
Right | 40 (40%) |
Left | 59 (60%) |
Additional glaucoma diagnosis | |
Pseudoexfoliative glaucoma | 3 (3.0%) |
Lens status | |
Phakic | 82 (83%) |
Pseudophakic | 17 (27%) |
Mean C:D ratio ± SD | 0.7 ± 0.2 |
Mean # medications (SD) | 2.21 (0.44) |
# Medications by classa | |
Alpha agonist | 18 (18.2%) |
Beta blocker | 80 (80.8%) |
Carbonic anhydrase inhibitor | 56 (56.6%) |
Prostaglandin analog | 61 (61.6%) |
Miotic (pilocarpine) | 4 (4.0%) |
Mean medicated IOP (mmHg) | 22.1 ± 3.3 |
Mean pachymetry (μm) | 541.0 ± 38.1 |
Mean post-washout IOP (mmHg) | 26.3 ± 3.5 |
C:D cup:disc ratio, IOP intraocular pressure
aSubjects could be on two or more medications